Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -137.40% is 26% above its 5-year average of -186.68%, near the high end of its 5-year range (-1649.50%–-112.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.74% above its 12-month average of -144.23%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -137.40%.
RETURN ON INVESTED CAPITAL (ROIC)
-137.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-144.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-421.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-186.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.74%
CURRENT VS 3Y AVG
+67.42%
CURRENT VS 5Y AVG
+26.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.45%
median of 794 covered companies
CURRENT VS SECTOR MEDIAN
-287.57%
vs the sector median at left
TuHURA Biosciences, Inc.
Market Cap
$121.68M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-144.23%
3Y Avg
-421.69%
5Y Avg
-186.68%
Market Cap
$121.23M
Return on Invested Capital (ROIC)
-28.87%
TTM Avg
-28.06%
3Y Avg
-25.36%
5Y Avg
-20.47%
Market Cap
$120.60M
Return on Invested Capital (ROIC)
-17.99%
TTM Avg
-23.22%
3Y Avg
-53.77%
5Y Avg
-63.92%
Market Cap
$120.58M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-41.34%
3Y Avg
-32.26%
5Y Avg
-28.21%
Market Cap
$120.52M
Return on Invested Capital (ROIC)
-142.06%
TTM Avg
-89.80%
3Y Avg
-79.42%
5Y Avg
-61.57%
Market Cap
$119.72M
Return on Invested Capital (ROIC)
-50.67%
TTM Avg
-131.41%
3Y Avg
-97.53%
5Y Avg
-74.13%
Market Cap
$124.98M
Return on Invested Capital (ROIC)
-74.08%
TTM Avg
-72.79%
3Y Avg
-71.36%
5Y Avg
-64.12%
Market Cap
$125.77M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-346.83%
3Y Avg
-231.85%
5Y Avg
-139.34%
Market Cap
$126.51M
Return on Invested Capital (ROIC)
-82.87%
TTM Avg
-100.14%
3Y Avg
-98.73%
5Y Avg
-97.80%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TuHURA Biosciences, Inc. (HURA) | $121.68M | -137.40% | -144.23% | -421.69% | -186.68% |
| Seer, Inc. (SEER)vs › | $121.23M | -28.87% | -28.06% | -25.36% | -20.47% |
| Cibus, Inc. (CBUS)vs › | $120.60M | -17.99% | -23.22% | -53.77% | -63.92% |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | -1.78% | -41.34% | -32.26% | -28.21% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $120.52M | -142.06% | -89.80% | -79.42% | -61.57% |
| Spruce Biosciences, Inc. (SPRB)vs › | $119.72M | -50.67% | -131.41% | -97.53% | -74.13% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.98M | -74.08% | -72.79% | -71.36% | -64.12% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $125.77M | N/A | -346.83% | -231.85% | -139.34% |
| Entera Bio Ltd. (ENTX)vs › | $126.51M | -82.87% | -100.14% | -98.73% | -97.80% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.49M | -61.84% | -30.30% | -57.06% | -116.42% |
ROIC
-137.4%
ROE
-165.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -137.40% |
| 2026-03-31 | -135.50% |
| 2025-12-31 | -146.99% |
| 2025-09-30 | -168.91% |
| 2025-06-30 | -132.36% |
| 2025-03-31 | -191.01% |
| 2024-12-31 | -112.16% |
| 2024-06-30 | -278.26% |
| 2024-03-31 | -1264.82% |
| 2023-06-30 | -1649.50% |
| 2023-03-31 | -235.95% |
| 2022-12-31 | -283.93% |
| 2022-09-30 | -220.31% |
| 2022-06-30 | -189.68% |
| 2022-03-31 | -250.27% |
| 2021-12-31 | -176.25% |
| 2021-09-30 | -127.45% |
| 2021-06-30 | -200.42% |
| 2021-03-31 | -104.86% |
| 2020-12-31 | -71.36% |
| 2020-09-30 | -44.38% |
| 2020-06-30 | -3094.27% |
| 2020-03-31 | -222.47% |
| 2019-12-31 | -145.45% |
| 2019-09-30 | -114.28% |
| 2019-06-30 | -426.85% |
| 2019-03-31 | -627.75% |
| 2018-12-31 | -466.03% |
| 2018-09-30 | -285.98% |
| 2018-06-30 | -205.55% |
| 2018-03-31 | -150.89% |
| 2017-12-31 | -191.53% |
| 2017-09-30 | -69.26% |
| 2017-06-30 | -125.95% |
